NL-OMON27814Other不适用
Phosphate Reduction Or Supplementation Intervention Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 入组人数
- 42
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Estimated GFR >30 mL /min/1.73 m2
排除标准
- •Current use of phosphate binder therapy
- •Hyperphosphatemia >2.00 mmol/L
研究者
相似试验
已完成
不适用
Hypophosphatemia during CRRTDiseases of The genitoruinary systemKCT0001341Konkuk University Medical Center70
已完成
4 期
Phosphate Lowering in CKD TrialChronic Kidney DiseaseCardiovascular DiseaseNCT02209636VA Office of Research and Development66
招募中
4 期
Effect of Calcium Carbonate for Reduction of Serum Fibroblast Growth Factor 23 (FGF 23) in Chronic Kidney Disease Stage 3Chronic kidney disease stage 3chronic kidney disease stage 3calcium carbonatephosphate binderFibroblast growth factor 23TCTR20150220001Siriraj Research and Development Fund Type 275
招募中
2 期
A single-centre feasibility study to evaluate the ability of Phoxilium to prevent hypophoshatemia compared to Hemosol B0 or Prismocol B22 during continuous renal replacement therapy in the intensive care unitRenal and Urogenital - Other renal and urogenital disordersAcute kidney injuryACTRN12623001152617Austin Health30
已完成
不适用
Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living AdultsHealthyChronic Kidney DiseaseNCT02620449University of Alabama at Birmingham50